Results 271 to 280 of about 368,214 (310)

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors, Christiane Angermann Angermann, John R Teerlink   +2 more
exaly  

HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833.

Biochemical Pharmacology, 1999
J. Drewe, H. Gutmann, Gert Fricker, Michael Török, Christoph Beglinger, Jörg Huwyler   +5 more
semanticscholar   +1 more source

The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment

Nature Reviews Clinical Oncology, 2023
Nicholas Turner
exaly  

Interactions of a protease inhibitor and other peptides with isolated brush border membranes from rat renal cortex

Naunyn-Schmiedeberg's Archives of Pharmacology, 1973
M. Just, E. Habermann
semanticscholar   +1 more source

In vivo interaction of the Kunitz protease inhibitor and of insulin with subcellular structures from rat renal cortex

Naunyn-Schmiedeberg's Archives of Pharmacology, 1975
M. Just
semanticscholar   +1 more source

Inhibition of Human Preadipocyte Proteasomal Activity by HIV Protease Inhibitors or Specific Inhibitor Lactacystin Leads to a Defect in Adipogenesis, Which Involves Matrix Metalloproteinase-9

Journal of Pharmacology and Experimental Therapeutics, 2007
S. de Barros, A. Zakaroff‐Girard, M. Lafontan, J. Galitzky, V. Bourlier   +4 more
semanticscholar   +1 more source

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cell, 2020
Markus Hoffmann, Nadine Krüger, Tobias S Schiergens   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

The adenosine pathway in immuno-oncology

Nature Reviews Clinical Oncology, 2020
Bertrand Allard, Laurence Buisseret, John Stagg   +2 more
exaly